Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enzymetrics Bioscience has developed a proprietary platform, licensed from Pacific Northwest National Laboratory, that enables direct measurement and analysis of human gut microbiome enzyme activities. This technology provides actionable data to guide clinical decisions in areas such as cancer treatment outcomes, gastrointestinal diseases, immunological disorders, and general microbiome health. The company is building its first commercial scientific team and laboratory operations in Philadelphia
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enzymetrics Bioscience.